Biotechnology News

April 2, 2012

CRANBURY, N.J.--(BUSINESS WIRE)--VaxInnate Corporation names Wayne Pisano as President, CEO and Board member. Pisano, who is the former CEO of sanofi pasteur, is a global leader in vaccine development, production and sales.

April 2, 2012

LEXINGTON, Mass. & CHICAGO--(BUSINESS WIRE)--RainDance Launches Comprehensive Sequencing Panel for Cancer Mutation Screening and Research

April 2, 2012

NEW YORK & DALLAS--(BUSINESS WIRE)--CTNeT selects Medidata Solutions as strategic partner and will build innovative, streamlined operations with Medidata’s clinical development technology platform.

April 2, 2012

WATERTOWN, Mass.--(BUSINESS WIRE)--Tetraphase Presents Data at ECCMID from Growing Portfolio of Next-Generation Antibiotic Candidates

April 2, 2012

NEW YORK--(BUSINESS WIRE)--Forest Laboratories, Inc. (NYSE: FRX) today announced that Forest Laboratories Holdings Limited (Forest), its wholly owned subsidiary, and Janssen Pharmaceutica NV (Janssen) entered into an agreement under which Forest...

April 2, 2012

LEXINGTON, Mass.--(BUSINESS WIRE)--Findings of recently completed research studies on phospho-protein analysis of the activation state of the MAP kinase pathway presented at AACR by Bioscale.

April 2, 2012

BURLINGTON, Mass.--(BUSINESS WIRE)--The increased use of targeted therapies will be a key factor driving growth of the colorectal cancer drug market in China.

April 2, 2012

BURLINGTON, Mass.--(BUSINESS WIRE)--AlloCure, Inc., a clinical stage biotechnology company focused on the treatment of kidney disease, today announced the closing of a $25 million Series B venture financing.

April 2, 2012

BOSTON--(BUSINESS WIRE)--Investigative sites worldwide see encouraging signs of financial recovery, according to a new 2012 CenterWatch study benchmarking global investigative site workload, staffing and financial performance

April 2, 2012

LONDON--(BUSINESS WIRE)--PolyTherics and Spirogen to develop antibody drug conjugates (ADCs) that combine site-specific conjugation chemistry with potent cytotoxic drugs to produce novel ADCs for the treatment of cancer.

April 2, 2012

WEST HAVEN, Conn.--(BUSINESS WIRE)--NanoViricides had its first pre-IND Meeting with US FDA for its influenza drug, NV-INF-1 on March 29.

April 2, 2012

PALO ALTO, Calif.--(BUSINESS WIRE)--CardioDx, Inc., a pioneer in the field of cardiovascular genomic diagnostics, today announced that Chief Medical Officer Mark Monane, M.D., will present an overview of the company and of Corus® CAD, the first...

April 2, 2012

LEXINGTON, Mass.--(BUSINESS WIRE)--Synageva BioPharma Corp. (“Synageva”) (NASDAQ:GEVA), a clinical stage biopharmaceutical company developing therapeutic products for rare disorders, announced today an expansion of its previous collaboration with...

April 2, 2012

STOCKHOLM--(BUSINESS WIRE)--Regulatory News: Precise Biometrics (STO:PREC) has now published its Annual Report for 2011 in both Swedish and English on its website www....

April 2, 2012

OSLO, Norway--(BUSINESS WIRE)--Regulatory News: According to the Norwegian Securities Trading Act, section 5-11, issuers of listed transferable securities are required to provide Oslo Stock Exchange with an annual statement of information made...

April 2, 2012

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Exelixis, Inc. (NASDAQ:EXEL) announced today that its lead compound, cabozantinib, will be the subject of nine separate data presentations at the upcoming Annual Meeting of the American Society of...

April 2, 2012

COPENHAGEN, Denmark--(BUSINESS WIRE)--Symphogen announced today the appointment of Martin Olin to the position of Chief Financial Officer. Symphogen also said it received the second of three tranches of capital specified in its €100 million 2011...

April 2, 2012

CAMBRIDGE, England--(BUSINESS WIRE)--Bicycle Therapeutics, a next generation biotherapeutics company, today announced the appointment of Rolf Günther, MD, PhD as Chief Executive Officer.

April 2, 2012

SAN DIEGO--(BUSINESS WIRE)--Illumina, Inc. (NASDAQ:ILMN) today announced estimated first quarter revenue of approximately $270 million. This number is based on a preliminary estimate and remains subject to review by Illumina’s independent...

April 2, 2012

GENEVA--(BUSINESS WIRE)--Therakos, Inc., a pioneer in the development of an innovative immune modulation therapy called extracorporeal photopheresis (ECP), today launched Lighting Up Lives, a 25-year anniversary campaign and year-long global...

April 2, 2012

JERUSALEM--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) announced today that it has commenced commercial launch of both Irbesartan and Irbesartan-Hydrochlorothiazide Tablets, the Company’s generic versions of Sanofi Aventis...

April 1, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) today presented new preclinical data for saridegib (IPI-926), its novel oral molecule that inhibits Smoothened, a key component of the Hedgehog pathway. Data...

April 1, 2012

NEW YORK--(BUSINESS WIRE)--Enzo Biochem Inc. (NYSE:ENZ) announced that the Company yesterday made its first peer-reviewed presentation of its novel AmpiProbe™ platform, encompassing low cost, and high sensitivity, real time nucleic acid...

April 1, 2012

CAESAREA, Israel--(BUSINESS WIRE)--Mazor Robotics Ltd (TASE:MZOR), the leader in innovative surgical robots and complementary products for spine surgery, today announced that Florida Hospital Carrollwood, a 120-bed community hospital in Tampa, FL...

March 31, 2012

CAMBRIDGE, Mass. & CHICAGO--(BUSINESS WIRE)--Tokai Pharmaceuticals, Inc., a biopharmaceutical company focused on developing new treatments for prostate cancer, today announced that its lead candidate galeterone (TOK-001) was well-tolerated...

March 31, 2012

LONDON--(BUSINESS WIRE)--At the 22nd ECCMID (European Congress of Clinical Microbiology and Infectious Diseases) in London, Bruker announces new protocols and reference libraries for mycobacteria and multicellular fungi to further extend the...

March 31, 2012

CHALFONT ST GILES, England & BURLINGTON, Mass.--(BUSINESS WIRE)--GE Healthcare, a unit of GE (NYSE:GE), and Dyax Corp. (NASDAQ:DYAX) today announced a licensing agreement for the development and commercialization of peptides binding to c-Met...

March 31, 2012

LONDON--(BUSINESS WIRE)--At the 22nd ECCMID (European Congress of Clinical Microbiology and Infectious Diseases) in London, Bruker announces a collaboration with UMCG within the new European Network for the Rapid Identification of Anaerobes (...

March 30, 2012

WALTHAM, Mass.--(BUSINESS WIRE)--PerkinElmer Highlights Innovative Solutions for Enabling Personalized Medicine in Cancer Research at AACR 2012

March 30, 2012

NEWTON, Mass.--(BUSINESS WIRE)--Galectin Therapeutics reports full year and fourth quarter 2011 financial results.

March 30, 2012

MORRISTOWN, N.J.--(BUSINESS WIRE)--QPharma, Inc., which provides consulting services to the pharma and life science industries, announces the promotion of Prajeep Kumar Thottupurath to the position of Chief Information Officer.

March 30, 2012

COLORADO SPRINGS, Colo.--(BUSINESS WIRE)--Cannabis Science, Inc. (OTCBB:CBIS) a pioneering U.S. biotech company developing pharmaceutical cannabis (marijuana) products, is pleased to announce that Dr. Melamede was featured on NBC Channel 12 News...

March 30, 2012

VÄSTRA FRÖLUNDA, Sweden--(BUSINESS WIRE)--Regulatory News: With reference to Chapter 4, Section 9 of the Swedish Financial Instruments Trading Act (SFS 1991:980), it is hereby announced that the new issue of Series B stock units during March 2012...

March 30, 2012

--(BUSINESS WIRE)--Pharmaceteutical manufacturer and distributor Company:   Taro Pharmaceutical Industries Ltd.   Headquarters Address: 14 Hakitor Street Haifa Bay 26110 Israel   Main Telephone: +97248475700   Ticker: TARO(NYSE)   Type of...

March 30, 2012

OSLO, Norway--(BUSINESS WIRE)--Regulatory News: Please find enclosed DiaGenic’s Annual Report for 2011....

March 30, 2012

MANASSAS, Va.--(BUSINESS WIRE)--ATCC, the premier biological materials resource and standards organization, announced its new depositor and material transfer agreements (MTA).

March 30, 2012

JERUSALEM--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announces the launch of the authorized generic of Provigil® (modafinil). Provigil® is marketed by Cephalon, Inc., a wholly owned subsidiary of Teva Pharmaceutical...

March 30, 2012

ST. LOUIS--(BUSINESS WIRE)--The American College of Rheumatology (ACR) Subcommittee on Osteoarthritis Guidelines has approved and issued several updates to clinical practice guidelines for the treatment of osteoarthritis (OA). The new guidelines...

March 30, 2012

EMERYVILLE, Calif.--(BUSINESS WIRE)--Amyris will participate in the several conferences during the second quarter of 2012.

March 30, 2012

OMAHA, Neb.--(BUSINESS WIRE)--Transgenomic, Inc. (OTCBB: TBIO) today announced that Jeana DaRe, Ph.D., Assistant CLIA Laboratory Director at Transgenomic, presented clinical findings from patients tested for nuclear mitochondrial disorders using...

March 30, 2012

AUSTIN, Texas--(BUSINESS WIRE)--Next Generation Sequencing $6.8 million commercialization award to Asuragen, Inc.

March 30, 2012

SEATTLE--(BUSINESS WIRE)--NanoString will launch 3 new products for the nCounter® Analysis System at the American Association of Cancer Research (AACR) Annual Meeting 2012: the Plex2, Cancer CNV, and Human v2 miRNA Assay Kits.

March 30, 2012

TEWKSBURY, Mass.--(BUSINESS WIRE)--Cambridge Heart, Inc. (OTCBB: CAMH), a developer of non-invasive diagnostic tests for cardiac disease, today reported results for its fourth quarter and full year ended December 31, 2011. Full financial...

March 30, 2012

ANN ARBOR, Mich.--(BUSINESS WIRE)--AlphaCore Pharma, a biopharmaceutical company, today announced the initiation of a Phase 1 study of ACP-501 (rhLCAT) in patients with stable coronary arterial disease.

March 30, 2012

WALTHAM, Mass.--(BUSINESS WIRE)--ImmunoGen, Inc. (Nasdaq: IMGN), a biotechnology company that develops targeted anticancer products, today announced that it will host a conference call at 8:00 am ET on Friday, March 30, 2012 to discuss the two...

March 30, 2012

WALTHAM, Mass.--(BUSINESS WIRE)--ImmunoGen, Inc. (Nasdaq: IMGN) today announced that it has initiated Phase II testing of its IMGN901 product candidate for first-line treatment of SCLC. The Phase II assessment begun today, also known as the NORTH...

March 30, 2012

DUBLIN--(BUSINESS WIRE)--Dublin - Research and Markets (http://www.researchandmarkets....

March 30, 2012

VÄSTRA FRÖLUNDA, Sweden--(BUSINESS WIRE)--Regulatory News: Artimplant AB: (STO:ARTIB) The Annual Report for the financial year 2011 is published through this press release and on the Company's homepage:...

March 30, 2012

SOLNA, Sweden--(BUSINESS WIRE)--Regulatory News: Aerocrine: (STO:AEROB) With reference to Chapter 4 Section 9 in ”lagen (1991:980) om handel med finansiella instrument” it’s hereby announced that subscription by exercise of options in Aerocrine...